- •Demyelinating diabetic sensorimotor polyneuropathy (DDSP) can be difficult to distinguish from CIDP.
- •Nerve ultrasound shows larger nerves in CIDP than DDSP.
- •Nerve ultrasound is useful as an additional tool in differentiating CIDP from DDSP.
Diabetic patients with poor glycaemic control can demonstrate demyelinating distal sensorimotor polyneuropathy (D-DSP) on electrophysiology. Distinguishing D-DSP from chronic inflammatory demyelinating polyneuropathy (CIDP) can be challenging. In this study, we investigated the role of nerve ultrasound in differentiating the two neuropathies. Nerve ultrasound findings of D-DSP patients (fulfilling the electrophysiological but not clinical criteria for CIDP) were compared with non-diabetic CIDP patients (fulfilling both criteria). We studied 108 and 95 nerves from 9 D-DSP and 10 CIDP patients respectively. CIDP patients had significantly larger cross-sectional areas of the median nerve at the mid-arm (17.0 ± 12.5 vs 8.7 ± 2.6; p = 0.005), ulnar nerve at the wrist (7.3 ± 3.1 vs 4.1 ± 1.0; p = 0.001), mid forearm (8.8 ± 5.3 vs 5.5 ± 1.5; p = 0.002) and mid-arm (14.5 ± 14.1 vs 7.5 ± 1.9; p = 0.013), and radial nerve at mid forearm (4.1 ± 2.4 vs 1.2 ± 0.4; p < 0.001). In comparison to D-DSP, CIDP patients had markedly larger nerves at the proximal and non-entrapment sites of the upper limbs, suggesting that nerve ultrasound is useful in differentiating the two neuropathies.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Journal of Clinical Neuroscience
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Natural history of peripheral neuropathy in patients with non-insulin dependent diabetes mellitus.N Eng J Med. 1995; 333: 89-94
- Modeling chronic glycemic exposure variables as correlates and predictors of microvascular complications of diabetes.Diab Care. 2006; 29: 2282-2288
- Conduction slowing in diabetic distal polyneuropathy.Muscle Nerve. 2002; 26: 232-237
- Conduction slowing in diabetic sensorimotor polyneuropathy.Diab Care. 2013; 36: 3684-3690
- Electrodiagnostic criteria in CIDP: comparison with diabetic neuropathy.Electromyogr Clin Neurophysiol. 2000; 40: 181-185
- Demyelinating neuropathy in diabetes mellitus.Arch Neurol. 2002; 59: 758-765
- Influence of diabetes mellitus on chronic inflammatory demyelinating polyneuropathy.Muscle Nerve. 2000; 23: 37-43
- Chronic inflammatory demyelinating polyradiculoneuropathy in diabetic patients.Muscle Nerve. 2003; 27: 465-470
- Chronic inflammatory demyelinating polyneuropathy in diabetics: motor conductions are important in the differential diagnosis with diabetic polyneuropathy.Clin Neurophysiol. 1999; 110: 705-711
- Chronic inflammatory demyelinating polyneuropathy (CIDP) in diabetics.J Neurol Sci. 1996; 142: 59-64
- Comparison of diabetes patients with ‘‘demyelinating’’ diabetic sensorimotor polyneuropathy to those diagnosed with CIDP.Brain Behav. 2013; 3: 656-663
- European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society – first revision.Eur J Neurol. 2010; 17: 356-363
- The characteristics of chronic inflammatory demyelinating polyneuropathy in patients with and without diabetes – an observational study.PLoS One. 2014; 9e89344
- Treatment responsiveness in CIDP patients with diabetes is associated with unique electrophysiological characteristics, and not with common criteria for CIDP.Expert Rev Clin Immunol. 2015; 11: 537-546
- Utility of the distal compound action potential duration for diagnosis of demyelinating neuropathies.J Peripher Nerv Syst. 2009; 14: 151-158
- A comparative study of chronic inflammatory demyelinating polyradiculoneuropathy with and without diabetes mellitus.Eur J Neurol. 2007; 14: 638-643
- Relationship between ultrasonographic nerve morphology and severity of diabetic sensorimotor polyneuropathy.Eur J Neurol. 2016; 23: 354-360
- Ultrasonography of palm to elbow segment of median nerve in different degrees of diabetic polyneuropathy.Clin Neurophysiol. 2014; 125: 844-848
- Morphological and functional changes in the diabetic peripheral nerve: using diagnostic ultrasound and neurosensory testing to select candidates for nerve decompression.J Am Podiatr Med Assoc. 2005; 95: 433-437
- Activity-dependent excitability changes suggest Na+/K+ pump dysfunction in diabetic polyneuropathy.Brain. 2008; 131: 1209-1216
- Sural nerve pathology in diabetic patients with minimal but progressive neuropathy.Diabetologica. 2005; 48: 578-585
- Fiber loss is primary and multifocal in sural nerves in diabetic polyneuropathy.Ann Neurol. 1986; 19: 425-439
- Peripheral nerve size in normal and patients with polyneuropathy: an ultrasound study.Muscle Nerve. 2009; 40: 960-966
- Derivation and validation of diagnostic criteria for chronic inflammatory demyelinating polyneuropathy.J Neurol Sci. 2009; 277: 1-8
- Pattern analysis of nerve enlargement using ultrasonography in chronic inflammatory demyelinating polyneuropathy.Clin Neurophysiol. 2014; 125: 1893-1899
- Diffuse spinal and intercostal nerve involvement in chronic inflammatory demyelinating polyradiculoneuropathy: MRI findings.Eur Radiol. 2003; 13: 230-234
- Hypertrophic neuritis due to chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): a postmortem pathological study.Muscle Nerve. 1996; 19: 163-169
Published online: August 22, 2018
Accepted: August 13, 2018
Received: May 2, 2018
© 2018 Elsevier Ltd. All rights reserved.